Mostrar el registro sencillo del ítem
dc.contributor.author
Ugalde Arbizu, Maider
dc.contributor.author
Aguilera Correa, John Jairo
dc.contributor.author
San Sebastian, Eider
dc.contributor.author
Páez, Paulina Laura
dc.contributor.author
Nogales, Estela
dc.contributor.author
Esteban, Jaime
dc.contributor.author
Gómez Ruiz, Santiago
dc.date.available
2024-02-09T15:22:49Z
dc.date.issued
2023-07
dc.identifier.citation
Ugalde Arbizu, Maider; Aguilera Correa, John Jairo; San Sebastian, Eider; Páez, Paulina Laura; Nogales, Estela; et al.; Antibacterial Properties of Mesoporous Silica Nanoparticles Modified with Fluoroquinolones and Copper or Silver Species; Multidisciplinary Digital Publishing Institute; Pharmaceuticals; 16; 7; 7-2023; 1-21
dc.identifier.uri
http://hdl.handle.net/11336/226652
dc.description.abstract
Antibiotic resistance is a global problem and bacterial biofilms contribute to its development. In this context, this study aimed to perform the synthesis and characterization of seven materials based on silica mesoporous nanoparticles functionalized with three types of fluoroquinolones, along with Cu2+ or Ag+ species to evaluate the antibacterial properties against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa, including clinical and multi-drug-resistant strains of S. aureus and P. aeruginosa. In addition, in order to obtain an effective material to promote wound healing, a well-known proliferative agent, phenytoin sodium, was adsorbed onto one of the silver-functionalized materials. Furthermore, biofilm studies and the generation of reactive oxygen species (ROS) were also carried out to determine the antibacterial potential of the synthesized materials. In this sense, the Cu2+ materials showed antibacterial activity against S. aureus and E. coli, potentially due to increased ROS generation (up to 3 times), whereas the Ag+ materials exhibited a broader spectrum of activity, even inhibiting clinical strains of MRSA and P. aeruginosa. In particular, the Ag+ material with phenytoin sodium showed the ability to reduce biofilm development by up to 55% and inhibit bacterial growth in a “wound-like medium” by up to 89.33%.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Multidisciplinary Digital Publishing Institute
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
BIOFILM
dc.subject
COPPER
dc.subject
FLUOROQUINOLONE
dc.subject
MSN
dc.subject
SILVER CHLORIDE
dc.subject.classification
Otras Nanotecnología
dc.subject.classification
Nanotecnología
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS
dc.title
Antibacterial Properties of Mesoporous Silica Nanoparticles Modified with Fluoroquinolones and Copper or Silver Species
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-02-09T11:06:25Z
dc.identifier.eissn
1424-8247
dc.journal.volume
16
dc.journal.number
7
dc.journal.pagination
1-21
dc.journal.pais
Suiza
dc.journal.ciudad
Basilea
dc.description.fil
Fil: Ugalde Arbizu, Maider. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Universidad del País Vasco; España. Universidad Rey Juan Carlos; España
dc.description.fil
Fil: Aguilera Correa, John Jairo. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Instituto de Salud Carlos III; España
dc.description.fil
Fil: San Sebastian, Eider. Universidad del País Vasco; España
dc.description.fil
Fil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
dc.description.fil
Fil: Nogales, Estela. Universidad Rey Juan Carlos; España
dc.description.fil
Fil: Esteban, Jaime. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Instituto de Salud Carlos III; España
dc.description.fil
Fil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; España
dc.journal.title
Pharmaceuticals
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/ph16070961
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1424-8247/16/7/961
Archivos asociados